$TDOC

Nueno Carlos sold $47K of TDOC

Nueno Carlos (President, International) sold 6,196 shares of Teladoc Health, Inc. (TDOC) at $7.63 on 2026-06-02.

Original reporting
SEC EDGAR · Nueno Carlos
Published Jun 3, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The key tradable element is the disclosed insider sale details (date, shares, price, and post-transaction holdings), which can influence short-term sentiment.

02

Market read

A single officer’s small open-market sale is primarily a sentiment/flow datapoint rather than a fundamental driver.

03

What to watch

The sale is not under a 10b5-1 plan, but the disclosed size ($47K) is small relative to typical market capitalization, limiting interpretability.

Relevance 7/10Novelty 6/10Timing: Filed June 3, covering a sale executed June 2.

Background

SEC Form 4 reports insider transactions (officers/directors/10% owners) in the issuer’s own stock.

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

Teladoc Health officer Nueno Carlos sold 6,196 shares in an open-market transaction worth about $47.3K, per SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment/flow optics.

Evidence & confidence

The filing is a small, non-plan (no 10b5-1) open-market sale by an officer, with no accompanying company-specific news.

Market effects

Minimal; insider selling in one healthcare/telehealth name is not a sector-wide signal on its own.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity/portfolio rebalancing and may not reflect negative expectations.

Key entities

  • Nueno Carlos

    President, International at Teladoc Health; reported an open-market sale of TDOC shares.

  • Teladoc Health, Inc.

    TDOC; insider selling disclosure filed via SEC EDGAR Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.